197 related articles for article (PubMed ID: 16355114)
1. Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression.
Schambach A; Bohne J; Baum C; Hermann FG; Egerer L; von Laer D; Giroglou T
Gene Ther; 2006 Apr; 13(7):641-5. PubMed ID: 16355114
[TBL] [Abstract][Full Text] [Related]
2. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
Werner M; Kraunus J; Baum C; Brocker T
Gene Ther; 2004 Jun; 11(12):992-1000. PubMed ID: 15029232
[TBL] [Abstract][Full Text] [Related]
3. Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS.
Zanta-Boussif MA; Charrier S; Brice-Ouzet A; Martin S; Opolon P; Thrasher AJ; Hope TJ; Galy A
Gene Ther; 2009 May; 16(5):605-19. PubMed ID: 19262615
[TBL] [Abstract][Full Text] [Related]
4. The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors.
Higashimoto T; Urbinati F; Perumbeti A; Jiang G; Zarzuela A; Chang LJ; Kohn DB; Malik P
Gene Ther; 2007 Sep; 14(17):1298-304. PubMed ID: 17597793
[TBL] [Abstract][Full Text] [Related]
5. Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
Brandtner EM; Kodajova P; Hlavaty J; Jandl G; Tabotta W; Salmons B; Günzburg WH; Hohenadl C
J Gene Med; 2008 Feb; 10(2):113-22. PubMed ID: 18076132
[TBL] [Abstract][Full Text] [Related]
6. Increased in vitro and in vivo transgene expression levels mediated through cis-acting elements.
Johansen J; Tornøe J; Møller A; Johansen TE
J Gene Med; 2003 Dec; 5(12):1080-9. PubMed ID: 14661183
[TBL] [Abstract][Full Text] [Related]
7. Self-inactivating retroviral vectors with improved RNA processing.
Kraunus J; Schaumann DH; Meyer J; Modlich U; Fehse B; Brandenburg G; von Laer D; Klump H; Schambach A; Bohne J; Baum C
Gene Ther; 2004 Nov; 11(21):1568-78. PubMed ID: 15372067
[TBL] [Abstract][Full Text] [Related]
8. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain.
Paterna JC; Moccetti T; Mura A; Feldon J; Büeler H
Gene Ther; 2000 Aug; 7(15):1304-11. PubMed ID: 10918501
[TBL] [Abstract][Full Text] [Related]
9. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors.
Schambach A; Wodrich H; Hildinger M; Bohne J; Kräusslich HG; Baum C
Mol Ther; 2000 Nov; 2(5):435-45. PubMed ID: 11082317
[TBL] [Abstract][Full Text] [Related]
10. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
[TBL] [Abstract][Full Text] [Related]
11. Multigene lentiviral vectors based on differential splicing and translational control.
Zhu Y; Feuer G; Day SL; Wrzesinski S; Planelles V
Mol Ther; 2001 Oct; 4(4):375-82. PubMed ID: 11592842
[TBL] [Abstract][Full Text] [Related]
12. Optimization of equine infectious anemia derived vectors for hematopoietic cell lineage gene transfer.
O'Rourke JP; Olsen JC; Bunnell BA
Gene Ther; 2005 Jan; 12(1):22-9. PubMed ID: 15550928
[TBL] [Abstract][Full Text] [Related]
13. WPRE-mediated enhancement of gene expression is promoter and cell line specific.
Klein R; Ruttkowski B; Knapp E; Salmons B; Günzburg WH; Hohenadl C
Gene; 2006 May; 372():153-61. PubMed ID: 16488559
[TBL] [Abstract][Full Text] [Related]
14. Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors.
Hlavaty J; Portsmouth D; Stracke A; Salmons B; Günzburg WH; Renner M
Virology; 2004 Dec; 330(1):351-60. PubMed ID: 15527860
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.
Laurie KL; Blundell MP; Baxendale HE; Howe SJ; Sinclair J; Qasim W; Brunsberg U; Thrasher AJ; Holmdahl R; Gustafsson K
Gene Ther; 2007 Dec; 14(23):1623-31. PubMed ID: 17851547
[TBL] [Abstract][Full Text] [Related]
16. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
17. Retroviral vector-mediated gene expression in hematopoietic cells.
Baum C; Richters A; Ostertag W
Curr Opin Mol Ther; 1999 Oct; 1(5):605-12. PubMed ID: 11249667
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer in human skin with different pseudotyped HIV-based vectors.
Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP
Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532
[TBL] [Abstract][Full Text] [Related]
19. Use of the hereditary persistence of fetal hemoglobin 2 enhancer to increase the expression of oncoretrovirus vectors for human gamma-globin.
Fragkos M; Anagnou NP; Tubb J; Emery DW
Gene Ther; 2005 Nov; 12(21):1591-600. PubMed ID: 15944728
[TBL] [Abstract][Full Text] [Related]
20. Assessment of CMV, RSV and SYN1 promoters and the woodchuck post-transcriptional regulatory element in adenovirus vectors for transgene expression in cortical neuronal cultures.
Boulos S; Meloni BP; Arthur PG; Bojarski C; Knuckey NW
Brain Res; 2006 Aug; 1102(1):27-38. PubMed ID: 16806110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
